PAMPLONA, Spain, July 7, 2011 - - ENRY Evaluation in 325 Patients Affirms Efficacy and Safety of Radioembolisation in Seriously-ill Patients and Identifies Specific Populations who may Benefit From Treatment Results of the multi-centre European Network on Radioembolisation with Yttrium-90 Resin Microspheres (ENRY) analysis of the long-term outcomes related to survival and safety of radioembolisation using SIR-Spheres in patients with inoperable primary liver tumours were published on-line today in Hepatology, the peer-reviewed journal of the American Association of the Study of Liver Diseases.[1] Evaluation of 325 patients with inoperable primary liver cancer (unresectable hepatocellular carcinoma), who were treated by teams of liver specialists, oncologists, interventional radiologists and nuclear medicine physicians at eight centres in Germany, Italy and Spain, provided "robust evidence of the survival outcomes achieved with radioembolisation, including patients with advanced disease and few treatment options," said Bruno Sangro, MD, PhD, Professor of Hepatology in the Liver Unit of the Clinical University of Navarra, Pamplona, Spain, and chair of the ENRY group.

PAMPLONA, Spain, October 1, 2010 - "It is increasingly difficult to receive financing and the financial crisis is weakening investment in R&D+i," said Conny Bogentoft, Chief Scientific Officer at Karolinska Development AB, during the third and last plenary session of the 5th International Meeting on Biotechnology, BioSpain 2010, organised by the Spanish Association of Biocompanies (ASEBIO) and the Government of Navarre through SODENA.

PAMPLONA, Spain, September 30, 2010 - The global biotechnology industry has been more resistant to the economic crisis than expected.

PAMPLONA, Spain, September 29, 2010 - The figures regarding BioSpain 2010 have beaten all previous records, to the extent that it has become the most important event in biotechnology in southern Europe.
Older News
19 20 21 22 23 24 25
26 27 28 29 30 1 2
3 4 5 6 7 8 9
Copyright© 2011 The Gaea Times